Safety and Efficacy of Intravenous Administration of SHED-CM for ALS

NCT06889857 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

BIOLOGICAL: The study drug is SHED-CM manufactured by U-Factor

Sponsor

Hitonowa Medical

Collaborators

[object Object]